Suppr超能文献

性别焦虑症医学管理的科学证据不足。

Deficiencies in Scientific Evidence for Medical Management of Gender Dysphoria.

作者信息

Hruz Paul W

机构信息

Washington University School of Medicine, St. Louis, MO, USA.

出版信息

Linacre Q. 2020 Feb;87(1):34-42. doi: 10.1177/0024363919873762. Epub 2019 Sep 20.

Abstract

UNLABELLED

Individuals who experience a gender identity that is discordant with biological sex are increasingly presenting to physicians for assistance in alleviating associated psychological distress. In contrast to prior efforts to identify and primarily address underlying psychiatric contributors to gender dysphoria, interventions that include uncritical social affirmation, use of gonadotropin-releasing hormone agonists to suppress normally timed puberty, and administration of cross-sex steroid hormones to induce desired secondary sex characteristics are now advocated by an emerging cohort of transgender medicine specialists. For patients with persistent gender dysphoria, surgery is offered to alter the appearance of breasts and genital organs. Efforts to address ethical concerns regarding this contentious treatment paradigm are dependent upon reliable evidence on immediate and long-term risks and benefits. Although strong recommendations have been made for invasive and potentially irreversible interventions, high-quality scientific data on the effects of this approach are generally lacking. Limitations of the existing transgender literature include general lack of randomized prospective trial design, small sample size, recruitment bias, short study duration, high subject dropout rates, and reliance on "expert" opinion. Existing data reveal significant intervention-associated morbidity and raise serious concern that the primary goal of suicide prevention is not achieved. In addition to substantial moral questions, adherence to established principles of evidence-based medicine necessitates a high degree of caution in accepting gender-affirming medical interventions as a preferred treatment approach. Continued consideration and rigorous investigation of alternate approaches to alleviating suffering in people with gender dysphoria are warranted.

SUMMARY

This paper provides an overview of what is currently known about people who experience a gender identity that differs from their biological sex and the associated desire to engage the medical profession in alleviating associated discomfort and distress. The scientific evidence used to support current recommendations for affirming one's preferred gender, halting normally timed puberty, administering cross-sex hormones, and surgically altering primary and secondary sexual traits are summarized and critically evaluated. Serious deficits in understanding the cause of this condition, the reasons for the marked increase in people presenting for medical care, together with immediate and long-term risks relative to benefit of medical intervention are exposed.

摘要

未标注

那些经历了与生理性别不一致的性别认同的人越来越多地向医生寻求帮助,以减轻相关的心理困扰。与之前识别并主要解决性别焦虑潜在精神因素的努力不同,包括不加批判的社会肯定、使用促性腺激素释放激素激动剂抑制正常时间的青春期,以及给予跨性别甾体激素以诱导期望的第二性征等干预措施,现在得到了一批新兴的跨性别医学专家的倡导。对于患有持续性性别焦虑的患者,会提供手术来改变乳房和生殖器官的外观。解决关于这种有争议的治疗模式的伦理问题的努力,依赖于关于直接和长期风险与益处的可靠证据。尽管已经对侵入性和潜在不可逆的干预措施提出了强烈建议,但关于这种方法效果的高质量科学数据普遍缺乏。现有跨性别文献的局限性包括普遍缺乏随机前瞻性试验设计、样本量小、招募偏差、研究持续时间短、受试者脱落率高以及依赖“专家”意见。现有数据揭示了与干预相关的显著发病率,并引发了对预防自杀这一首要目标未实现的严重担忧。除了大量的道德问题外,遵循循证医学的既定原则,在将性别肯定性医疗干预作为首选治疗方法时需要高度谨慎。对于缓解性别焦虑患者痛苦的替代方法,仍需持续考虑并进行严格调查。

总结

本文概述了目前对于那些经历了与其生理性别不同的性别认同以及相关的寻求医疗专业帮助以减轻相关不适和困扰的愿望的人群的了解。用于支持当前关于确认首选性别、停止正常时间的青春期、给予跨性别激素以及手术改变第一和第二性征的建议的科学证据,在此进行了总结和批判性评估。暴露了在理解这种情况的原因、寻求医疗护理的人数显著增加的原因,以及相对于医疗干预益处的直接和长期风险方面存在的严重不足。

相似文献

1
Deficiencies in Scientific Evidence for Medical Management of Gender Dysphoria.
Linacre Q. 2020 Feb;87(1):34-42. doi: 10.1177/0024363919873762. Epub 2019 Sep 20.
3
[Transgender and Gender Dysphoria: Viewpoints on Clinical Care and Psychological Stress].
Hu Li Za Zhi. 2023 Feb;70(1):17-22. doi: 10.6224/JN.202302_70(1).04.
4
5
Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society Clinical Practice Guideline.
J Clin Endocrinol Metab. 2017 Nov 1;102(11):3869-3903. doi: 10.1210/jc.2017-01658.
7
The Bioethical Dilemma of Gender-Affirming Therapy in Children and Adolescents.
Linacre Q. 2021 Aug;88(3):259-271. doi: 10.1177/0024363921989475. Epub 2021 Feb 17.
8
Continuation of gender-affirming hormones in transgender people starting puberty suppression in adolescence: a cohort study in the Netherlands.
Lancet Child Adolesc Health. 2022 Dec;6(12):869-875. doi: 10.1016/S2352-4642(22)00254-1. Epub 2022 Oct 21.
9
Gonadal suppressive and cross-sex hormone therapy for gender dysphoria in adolescents and adults.
Pharmacotherapy. 2014 Dec;34(12):1282-97. doi: 10.1002/phar.1487. Epub 2014 Sep 15.
10
The Effects of Gender-Affirming Hormone Therapy on Quality of Life: The Importance of Research on Youth.
Healthcare (Basel). 2024 Jul 4;12(13):1336. doi: 10.3390/healthcare12131336.

引用本文的文献

1
Gender Identity Disorders: Current Medical and Social Paradigm and the ICD-11 Innovations.
Consort Psychiatr. 2021 May 25;2(2):54-61. doi: 10.17816/CP68. eCollection 2021.
2
Current Challenges for Conscientious Objection by Physicians in Spain.
Linacre Q. 2024 Feb;91(1):29-38. doi: 10.1177/00243639231184352. Epub 2023 Aug 10.
3
Caring for Our Human Nature.
Linacre Q. 2023 Aug;90(3):256-259. doi: 10.1177/00243639221097943. Epub 2022 May 30.
4
A systematic review of psychosocial functioning changes after gender-affirming hormone therapy among transgender people.
Nat Hum Behav. 2023 Aug;7(8):1320-1331. doi: 10.1038/s41562-023-01605-w. Epub 2023 May 22.
5
Defining Desistance: Exploring Desistance in Transgender and Gender Expansive Youth Through Systematic Literature Review.
Transgend Health. 2022 Jun 13;7(3):189-212. doi: 10.1089/trgh.2020.0129. eCollection 2022 Jun.
6
Referral vs Transfer of Care: Ethical Options When Values Differ.
Linacre Q. 2022 Feb;89(1):36-46. doi: 10.1177/00243639211055970. Epub 2021 Dec 6.
7
The Bioethical Dilemma of Gender-Affirming Therapy in Children and Adolescents.
Linacre Q. 2021 Aug;88(3):259-271. doi: 10.1177/0024363921989475. Epub 2021 Feb 17.
8
The Vatican Opinion on Gender Theory.
Linacre Q. 2021 Feb;88(1):37-41. doi: 10.1177/0024363920933111. Epub 2020 Jun 17.

本文引用的文献

1
Buying time or arresting development? The dilemma of administering hormone blockers in trans children and adolescents.
Porto Biomed J. 2017 Sep-Oct;2(5):153-156. doi: 10.1016/j.pbj.2017.06.001. Epub 2017 Jul 5.
2
Gender-affirming hormones and surgery in transgender children and adolescents.
Lancet Diabetes Endocrinol. 2019 Jun;7(6):484-498. doi: 10.1016/S2213-8587(18)30305-X. Epub 2018 Dec 6.
3
Genetic Link Between Gender Dysphoria and Sex Hormone Signaling.
J Clin Endocrinol Metab. 2019 Feb 1;104(2):390-396. doi: 10.1210/jc.2018-01105.
4
Parent reports of adolescents and young adults perceived to show signs of a rapid onset of gender dysphoria.
PLoS One. 2018 Aug 16;13(8):e0202330. doi: 10.1371/journal.pone.0202330. eCollection 2018.
5
Cardiovascular health in transgender people.
Rev Endocr Metab Disord. 2018 Sep;19(3):243-251. doi: 10.1007/s11154-018-9454-3.
6
Cross-sex Hormones and Acute Cardiovascular Events in Transgender Persons: A Cohort Study.
Ann Intern Med. 2018 Aug 21;169(4):205-213. doi: 10.7326/M17-2785. Epub 2018 Jul 10.
7
Comparing the Healthcare Utilization and Engagement in a Sample of Transgender and Cisgender Bisexual+ Persons.
Arch Sex Behav. 2019 Jan;48(1):255-260. doi: 10.1007/s10508-018-1164-0. Epub 2018 Apr 9.
8
Chosen Name Use Is Linked to Reduced Depressive Symptoms, Suicidal Ideation, and Suicidal Behavior Among Transgender Youth.
J Adolesc Health. 2018 Oct;63(4):503-505. doi: 10.1016/j.jadohealth.2018.02.003. Epub 2018 Mar 30.
9
Transgender Associations and Possible Etiology: A Literature Review.
Cureus. 2017 Dec 24;9(12):e1984. doi: 10.7759/cureus.1984.
10
The Amsterdam Cohort of Gender Dysphoria Study (1972-2015): Trends in Prevalence, Treatment, and Regrets.
J Sex Med. 2018 Apr;15(4):582-590. doi: 10.1016/j.jsxm.2018.01.016. Epub 2018 Feb 17.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验